Cognitive Prefrail and Frailty, and Motoric Cognitive Risk Syndrome: Prevalence and Association With Incident Adverse Health Events
Trial Summary
What is the purpose of this trial?
We defined a new and early condition in the spectrum of cognitive frailty: the "cognitive-prefrailty" which is a combination of prefrailty stage and subjective cognitive impairment (SCI). This study aims to: (1) examine and compare the prevalence of cognitive-prefrailty, cognitive frailty and motoric cognitive risk syndrome (MCR) syndromes in participants of the Canadian Longitudinal Study of Aging (CLSA) using the (tracking and comprehensive) baseline assessment, (2) examine the association of cognitive-prefrailty, cognitive frailty and MCR syndromes with incident adverse health events using the information collected during the first CLSA 18-month follow-up, and (3) compare the criteria performances (i.e., sensitivity, specificity, positive predictive value, negative predictive value, area under receiver operating characteristic curve, positive and negative likelihood ratio) for incident adverse health events of the cognitive-prefrailty, cognitive frailty and MCR syndromes.
Research Team
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Data Collection (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jewish General Hospital
Lead Sponsor
Dr. Justin Cross
Jewish General Hospital
Chief Medical Officer since 2023
MD
Dr. Lawrence Rosenberg
Jewish General Hospital
Chief Executive Officer since 2015
MSc and PhD in Experimental Surgery from McGill University, Master of Engineering from the University of Waterloo